| SC 13G | 2021-02-09 | LAV Prescience Ltd | Passage BIO, Inc. | 2,417,328 | 5.3% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Passage BIO, Inc. | 5,278,100 | 11.6% | EDGAR |
| SC 13D/A | 2021-01-28 | ORBIMED ADVISORS LLC | Passage BIO, Inc. | 5,947,323 | 11.2% | EDGAR |
| SC 13D/A | 2021-01-27 | Frazier Life Sciences IX, L.P. | Passage BIO, Inc. | 5,009,219 | 9.5% | EDGAR |
| SC 13G | 2020-06-10 | FMR LLC | Passage BIO, Inc. | 4,627,598 | 10.2% | EDGAR |
| SC 13D | 2020-03-13 | Versant Venture Capital VI, L.P. | Passage BIO, Inc. | 4,026,417 | 9.2% | EDGAR |
| SC 13G | 2020-03-12 | Access Industries Holdings LLC | Passage BIO, Inc. | 2,616,630 | 5.9% | EDGAR |
| SC 13D | 2020-03-09 | ORBIMED ADVISORS LLC | Passage BIO, Inc. | 5,947,323 | 13.5% | EDGAR |
| SC 13D | 2020-03-09 | Frazier Life Sciences IX, L.P. | Passage BIO, Inc. | 5,009,219 | 10.9% | EDGAR |
| SC 13G | 2020-03-06 | Vivo Capital VIII, LLC | Passage BIO, Inc. | 2,243,497 | 4.9% | EDGAR |